| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 35,034 | 34,852 | 33,511 | 34,299 | | Cost of Revenue | 7,431 | 8,278 | 9,755 | 10,988 | | | Gross Profit | 27,603 | 26,574 | 23,756 | 23,311 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 13,097 | 14,153 | 12,687 | 12,338 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 5,725 | 4,936 | 4,516 | 2,529 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 8,781 | 7,485 | 6,553 | 8,444 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 8,781 | 7,485 | 6,553 | 8,444 | | Interest Expense | 837 | 1,014 | 1,171 | 1,934 | | Income Before Tax | 7,944 | 6,471 | 5,382 | 6,510 | | Income Tax Expense | 2,677 | 2,011 | 1,512 | 2,071 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,267 | 4,460 | 3,870 | 4,439 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,267 | 4,460 | 3,870 | 4,439 | | Preferred Stock And Other Adjustments | (801) | (800) | (290) |
-
| | | Net Income Applicable To Common Shares | $4,466 | $3,660 | $3,580 | $4,439 |
|
0.31% Nasdaq 
Income Statement
